Opportunities for improving cancer treatment using systems biology.
暂无分享,去创建一个
Jeffrey T. Chang | Andrea Bild | Adam L. Cohen | Jeffrey T. Chang | Jason I. Griffiths | Veronica Jones | Ravi Salgia | A. Bild | R. Salgia | A. Cohen | Veronica C Jones | J. Griffiths | A. Cohen
[1] Éva E Plagányi,et al. Future recovery of baleen whales is imperiled by climate change , 2019, Global change biology.
[2] Jeong Eon Lee,et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer , 2017, Nature Communications.
[3] P. Fortina,et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.
[4] Hua Chen,et al. Targeting protein kinases to reverse multidrug resistance in sarcoma. , 2016, Cancer treatment reviews.
[5] Mark W Schwartz,et al. A resource ratio theory of cooperation. , 2010, Ecology letters.
[6] I. Ionita-Laza,et al. Estimating the number of unseen variants in the human genome , 2009, Proceedings of the National Academy of Sciences.
[7] A. Suresh,et al. Optimal prediction of the number of unseen species , 2016, Proceedings of the National Academy of Sciences.
[8] Shaker A. Mousa,et al. The Role of Angiogenesis in Cancer Treatment , 2017, Biomedicines.
[9] S. Sager,et al. Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function. , 2011, Mathematical biosciences.
[10] H. Shimizu,et al. Prediction of Cross-resistance and Collateral Sensitivity by Gene Expression profiles and Genomic Mutations , 2017, Scientific Reports.
[11] J. Gómez,et al. Are Mixed-Species Bird Flocks Stable through Two Decades? , 2013, The American Naturalist.
[12] Stephen P Ellner,et al. Does rapid evolution matter? Measuring the rate of contemporary evolution and its impacts on ecological dynamics. , 2011, Ecology letters.
[13] S. Rajappa,et al. Integrating Osimertinib in Clinical Practice for Non-Small Cell Lung Cancer Treatment , 2019, Advances in Therapy.
[14] L. Norton,et al. The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens , 2006, Nature Clinical Practice Oncology.
[15] Eytan Ruppin,et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma , 2018, Nature Medicine.
[16] Lei Zheng,et al. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Francisco Azuaje,et al. Computational models for predicting drug responses in cancer research , 2016, Briefings Bioinform..
[18] Clotilde Théry,et al. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.
[19] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[20] Jianhua Xing,et al. Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition. , 2013, Biophysical journal.
[21] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[22] Giles Hooker,et al. Parameterizing state–space models for infectious disease dynamics by generalized profiling: measles in Ontario , 2011, Journal of The Royal Society Interface.
[23] Robert K. Colwell,et al. Estimating terrestrial biodiversity through extrapolation. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[24] Yvan Saeys,et al. A comparison of single-cell trajectory inference methods , 2019, Nature Biotechnology.
[25] J. Wietrzyk,et al. Antiangiogenic cancer treatment: The great discovery and greater complexity (Review) , 2016, International journal of oncology.
[26] Amir Abdollahi,et al. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. , 2010, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[27] Jonathan M. Levine,et al. Effects of rapid evolution on species coexistence , 2019, Proceedings of the National Academy of Sciences.
[28] I. Fidler,et al. The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs , 2011, International journal of cancer.
[29] Giuseppe Curigliano,et al. Targeting the microenvironment in solid tumors. , 2018, Cancer treatment reviews.
[30] G. Demetri,et al. Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. , 1989, Blood.
[31] Evan A. Clayton,et al. Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy , 2018, Scientific Reports.
[32] Madhav V. Marathe,et al. Systems Modeling of Molecular Mechanisms Controlling Cytokine-driven CD4+ T Cell Differentiation and Phenotype Plasticity , 2013, PLoS Comput. Biol..
[33] Lucy Ireland,et al. Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance , 2018, Front. Cell Dev. Biol..
[34] Robert A. Gatenby,et al. Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy , 2019, Clinical Cancer Research.
[35] Paolo Vineis,et al. Deciphering the complex: Methodological overview of statistical models to derive OMICS‐based biomarkers , 2013, Environmental and molecular mutagenesis.
[36] K. Polyak,et al. Tumorigenesis: it takes a village , 2015, Nature Reviews Cancer.
[37] William S. Hlavacek,et al. Prediction of Optimal Drug Schedules for Controlling Autophagy , 2018, Scientific Reports.
[38] Heyrim Cho,et al. Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy , 2017, Bulletin of Mathematical Biology.
[39] Justin M. Wozniak,et al. High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow , 2017, BMC Bioinformatics.
[40] Sayan Mukherjee,et al. A unifying framework for interpreting and predicting mutualistic systems , 2019, Nature Communications.
[41] Shuigeng Zhou,et al. Single-cell trajectories reconstruction, exploration and mapping of omics data with STREAM , 2019, Nature Communications.
[42] Lin Zhou,et al. Cancer‐associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma , 2017, Cancer medicine.
[43] Yi Qin,et al. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer , 2018, Theranostics.
[44] Robert A Gatenby,et al. Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies , 2017, bioRxiv.
[45] Brent S. Pedersen,et al. Combating subclonal evolution of resistant cancer phenotypes , 2017, Nature Communications.
[46] Joel s. Brown,et al. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer , 2017, Nature Communications.
[47] Carsten Denkert,et al. The landscape of metastatic progression patterns across major human cancers , 2014, Oncotarget.
[48] Herschel Rabitz,et al. Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability , 2018, Nature Communications.
[49] M. Piccart-Gebhart,et al. Mammaprint™: a comprehensive review. , 2019, Future oncology.
[50] E. Song,et al. Turning foes to friends: targeting cancer-associated fibroblasts , 2018, Nature Reviews Drug Discovery.
[51] P. R. Atsatt,et al. Plant Defense Guilds , 1976, Science.
[52] Shan Jiang,et al. Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors. , 2019, Cell reports.
[53] L. R. Benjamin,et al. The theory and application of plant competition models: an agronomic perspective. , 2003, Annals of Botany.
[54] Amy M. Sitapati,et al. NCCN Guidelines Insights: Breast Cancer, Version 3.2018. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[55] W. Kaelin,et al. The VHL/HIF axis in clear cell renal carcinoma. , 2013, Seminars in cancer biology.
[56] Kazuyuki Aihara,et al. Personalizing Androgen Suppression for Prostate Cancer Using Mathematical Modeling , 2018, Scientific Reports.
[57] Robert Tibshirani,et al. DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity , 2018, Proceedings of the National Academy of Sciences.
[58] Jean Clairambault,et al. Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations , 2016, Biology Direct.
[59] Ralph Weissleder,et al. Successful Anti‐PD‐1 Cancer Immunotherapy Requires T Cell‐Dendritic Cell Crosstalk Involving the Cytokines IFN‐&ggr; and IL‐12 , 2018, Immunity.
[60] E. Leigh. The evolution of mutualism , 2010, Journal of evolutionary biology.
[61] Nasser K. Altorki,et al. The lung microenvironment: an important regulator of tumour growth and metastasis , 2018, Nature Reviews Cancer.
[62] Brett J Furnas,et al. Detecting diversity: emerging methods to estimate species diversity. , 2014, Trends in ecology & evolution.
[63] Nicola Miller,et al. The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre , 2014, European journal of cancer.
[64] J. Hughes,et al. Counting the Uncountable: Statistical Approaches to Estimating Microbial Diversity , 2001, Applied and Environmental Microbiology.
[65] Rodrigo Ramos-Jiliberto,et al. A conceptual framework for studying the strength of plant-animal mutualistic interactions. , 2015, Ecology letters.
[66] Mollie E. Brooks,et al. Generalized linear mixed models: a practical guide for ecology and evolution. , 2009, Trends in ecology & evolution.
[67] K. Pienta,et al. Evolution of cooperation among tumor cells , 2006, Proceedings of the National Academy of Sciences.
[68] Takehiko Yamanaka,et al. Optimal management strategy of insecticide resistance under various insect life histories: Heterogeneous timing of selection and interpatch dispersal , 2017, Evolutionary applications.
[69] S. Caja,et al. Exosome-Based Cell-Cell Communication in the Tumor Microenvironment , 2018, Front. Cell Dev. Biol..
[70] Atsushi Kawabata,et al. Combining microvolume isotope analysis and numerical simulation to reproduce fish migration history , 2018, Methods in Ecology and Evolution.
[71] Krister Wennerberg,et al. Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression , 2017, Bioinform..
[72] Richard A. Flavell,et al. The polarization of immune cells in the tumour environment by TGFβ , 2010, Nature Reviews Immunology.
[73] P. Sean Walsh,et al. Analytical performance of a bronchial genomic classifier , 2016, BMC Cancer.
[74] Tyvette S. Hilliard. The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment , 2018, Cancers.
[75] Yi Yin,et al. Automatic classification of cervical cancer from cytological images by using convolutional neural network , 2018, Bioscience reports.
[76] H. Cho,et al. Modelling acute myeloid leukaemia in a continuum of differentiation states , 2018, Letters in biomathematics.
[77] Varun Rastogi,et al. Tumour Angiogenesis and Angiogenic Inhibitors: A Review. , 2015, Journal of clinical and diagnostic research : JCDR.
[78] D. Welch,et al. Defining the Hallmarks of Metastasis. , 2019, Cancer research.
[79] Bonnie Berger,et al. Generalizable and Scalable Visualization of Single-Cell Data Using Neural Networks. , 2018, Cell systems.
[80] Regina S Baucom,et al. Evolutionary and ecological insights from herbicide-resistant weeds: what have we learned about plant adaptation, and what is left to uncover? , 2019, The New phytologist.
[81] M. L. Martins,et al. A multiscale model for plant invasion through allelopathic suppression , 2010, Biological Invasions.
[82] N. Maishi,et al. Tumor endothelial cells accelerate tumor metastasis , 2017, Cancer science.
[83] Lenwood S. Heath,et al. DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data , 2017, bioRxiv.
[84] J. Dering,et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro , 2009, Breast Cancer Research.
[85] Richard O Hynes,et al. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. , 2012, Cancer discovery.
[86] Jun Li,et al. Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma. , 2019, Cancer cell.
[87] T. Coroller,et al. Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging , 2019, Clinical Cancer Research.
[88] F. Bahrami,et al. An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol. , 2017, Mathematical biosciences.
[89] Bo Wang,et al. Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning , 2016, Nature Methods.
[90] Shridar Ganesan,et al. Tumor Suppressor Tolerance: Reversion Mutations in BRCA1 and BRCA2 and Resistance to PARP Inhibitors and Platinum. , 2018, JCO precision oncology.
[91] Bernhard O. Palsson,et al. The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models , 2013, BMC Systems Biology.
[92] Bin Huang,et al. RACIPE: a computational tool for modeling gene regulatory circuits using randomization , 2017, bioRxiv.
[93] Margaret P. Chapman,et al. Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer , 2018, Nature Communications.
[94] Carlos L Arteaga,et al. Cdk Inhibitor p27Kip1 and Hormone Dependence in Breast Cancer , 2004, Clinical Cancer Research.
[95] Rui Zhao,et al. Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients , 2018, PLoS Comput. Biol..
[96] A Forsman,et al. Rethinking phenotypic plasticity and its consequences for individuals, populations and species , 2014, Heredity.
[97] L Biganzoli,et al. Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[98] Timothy Daley,et al. Applications of species accumulation curves in large-scale biological data analysis , 2015, Quantitative Biology.
[99] Ying Cheng,et al. Osimertinib in Untreated EGFR‐Mutated Advanced Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.